% alzhub.org library filter
% Source: https://alzhub.org/research?author=Galasko+D&access=free
% 15 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{sano2011-21795660,
  author  = {Sano, M. and Bell, K. L. and Galasko, D. and Galvin, J. E. and Thomas, R. G. and van Dyck, C. H. and Aisen, P. S.},
  title   = {{A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease}},
  journal = {Neurology},
  year    = {2011},
  doi     = {10.1212/wnl.0b013e318228bf11},
  pmid    = {21795660},
  url     = {https://doi.org/10.1212/wnl.0b013e318228bf11}
}

@article{ornish2024-38849944,
  author  = {Ornish, D. and Madison, C. and Kivipelto, M. and Kemp, C. and McCulloch, C. E. and Galasko, D. and Artz, J. and Rentz, D. and others},
  title   = {{Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01482-z},
  pmid    = {38849944},
  url     = {https://doi.org/10.1186/s13195-024-01482-z}
}

@article{palmqvist2025-40729527,
  author  = {Palmqvist, S. and Whitson, H. E. and Allen, L. A. and Suarez-Calvet, M. and Galasko, D. and Karikari, T. K. and Okrahvi, H. R. and Paczynski, M. and Schindler, S. E. and Teunissen, C. E. and others},
  title   = {{Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70535},
  pmid    = {40729527},
  url     = {https://doi.org/10.1002/alz.70535}
}

@article{besser2018-30376508,
  author  = {Besser, L. and Kukull, W. and Knopman, D. S. and Chui, H. and Galasko, D. and Weintraub, S. and Jicha, G. and Carlsson, C. and others},
  title   = {{Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2018},
  doi     = {10.1097/wad.0000000000000279},
  pmid    = {30376508},
  url     = {https://doi.org/10.1097/wad.0000000000000279}
}

@article{galasko2014-24696507,
  author  = {Galasko, D. and Bell, J. and Mancuso, J. Y. and Kupiec, J. W. and Sabbagh, M. N. and van Dyck, C. and Thomas, R. G. and Aisen, P. S. and others},
  title   = {{Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease}},
  journal = {Neurology},
  year    = {2014},
  doi     = {10.1212/wnl.0000000000000364},
  pmid    = {24696507},
  url     = {https://doi.org/10.1212/wnl.0000000000000364}
}

@article{petersen2005-15829527,
  author  = {Petersen, R. C. and Thomas, R. G. and Grundman, M. and Bennett, D. and Doody, R. and Ferris, S. and Galasko, D. and Jin, S. and others},
  title   = {{Vitamin E and donepezil for the treatment of mild cognitive impairment}},
  journal = {The New England journal of medicine},
  year    = {2005},
  doi     = {10.1056/nejmoa050151},
  pmid    = {15829527},
  url     = {https://doi.org/10.1056/nejmoa050151}
}

@article{sabbagh2011-21192237,
  author  = {Sabbagh, M. N. and Agro, A. and Bell, J. and Aisen, P. S. and Schweizer, E. and Galasko, D.},
  title   = {{PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2011},
  doi     = {10.1097/wad.0b013e318204b550},
  pmid    = {21192237},
  url     = {https://doi.org/10.1097/wad.0b013e318204b550}
}

@article{schindler2024-38866966,
  author  = {Schindler, S. E. and Galasko, D. and Pereira, A. C. and Rabinovici, G. D. and Salloway, S. and Suárez-Calvet, M. and Khachaturian, A. S. and Mielke, M. M. and Udeh-Momoh, C. and Weiss, J. and Batrla, R. and Bozeat, S. and others},
  title   = {{Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease}},
  journal = {Nature Reviews Neurology},
  year    = {2024},
  doi     = {10.1038/s41582-024-00977-5},
  pmid    = {38866966},
  url     = {https://doi.org/10.1038/s41582-024-00977-5}
}

@article{dubois2024-39483064,
  author  = {Dubois, B. and Villain, N. and Schneider, L. and Fox, N. and Campbell, N. and Galasko, D. and Kivipelto, M. and Jessen, F. and others},
  title   = {{Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation}},
  journal = {JAMA neurology},
  year    = {2024},
  doi     = {10.1001/jamaneurol.2024.3770},
  pmid    = {39483064},
  url     = {https://doi.org/10.1001/jamaneurol.2024.3770}
}

@article{bartl2021-34618817,
  author  = {Bartl, M. and Dakna, M. and Galasko, D. and Hutten, S. J. and Foroud, T. and Quan, M. and Marek, K. and Siderowf, A. and others},
  title   = {{Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease}},
  journal = {PloS one},
  year    = {2021},
  doi     = {10.1371/journal.pone.0257372},
  pmid    = {34618817},
  url     = {https://doi.org/10.1371/journal.pone.0257372}
}

@article{shi2011-21400565,
  author  = {Shi, M. and Bradner, J. and Hancock, A. M. and Chung, K. A. and Quinn, J. F. and Peskind, E. R. and Galasko, D. and Jankovic, J. and others},
  title   = {{Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression}},
  journal = {Annals of neurology},
  year    = {2011},
  doi     = {10.1002/ana.22311},
  pmid    = {21400565},
  url     = {https://doi.org/10.1002/ana.22311}
}

@article{kalaria2008-18667359,
  author  = {Kalaria, R. N. and Maestre, G. E. and Arizaga, R. and Friedland, R. P. and Galasko, D. and Hall, K. and Luchsinger, J. A. and Ogunniyi, A. and others},
  title   = {{Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors}},
  journal = {The Lancet. Neurology},
  year    = {2008},
  doi     = {10.1016/s1474-4422(08)70169-8},
  pmid    = {18667359},
  url     = {https://doi.org/10.1016/s1474-4422(08)70169-8}
}

@article{galasko2019-31853477,
  author  = {Galasko, D. and Xiao, M. and Xu, D. and Smirnov, D. and Salmon, D. P. and Dewit, N. and Vanbrabant, J. and Jacobs, D. and others},
  title   = {{Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2019},
  doi     = {10.1016/j.trci.2019.11.002},
  pmid    = {31853477},
  url     = {https://doi.org/10.1016/j.trci.2019.11.002}
}

@article{tsiknia2022-35768637,
  author  = {Tsiknia, A. A. and Edland, S. D. and Sundermann, E. E. and Reas, E. T. and Brewer, J. B. and Galasko, D. and Banks, S. J. and others},
  title   = {{Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression}},
  journal = {Molecular psychiatry},
  year    = {2022},
  doi     = {10.1038/s41380-022-01675-8},
  pmid    = {35768637},
  url     = {https://doi.org/10.1038/s41380-022-01675-8}
}

@article{davis1997-9114023,
  author  = {Davis, R. E. and Miller, S. and Herrnstadt, C. and Ghosh, S. S. and Fahy, E. and Shinobu, L. A. and Galasko, D. and Thal, L. J. and others},
  title   = {{Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease}},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  year    = {1997},
  doi     = {10.1073/pnas.94.9.4526},
  pmid    = {9114023},
  url     = {https://doi.org/10.1073/pnas.94.9.4526}
}